Insmed Inc
(FRA:IM8N)
€
66.5
-1 (-1.52%)
Market Cap: 11.45 Bil
Enterprise Value: 11.43 Bil
PE Ratio: 0
PB Ratio: 308.84
GF Score: 61/100 Insmed Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 09, 2021 / 06:10PM GMT
Release Date Price:
€22
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
Okay. Good afternoon, everyone, and welcome to the 2:10 session on day 2 of the Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I cover U.S. and U.S. -- European, excuse me, biopharma names here at the firm. It's my great pleasure to be hosting Insmed today on a fireside chat or in a fireside chat. And with that, let me welcome the company's CEO, Will Lewis. Will, it's great to see you again, and thanks for joining us.
William H. Lewis
Insmed Incorporated - President, CEO & Chairman
Thanks for having me, Graig. Really appreciate it.
Questions & Answers
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
Okay. Great. Maybe just to -- from a high-level perspective, let's why don't we start pretty simply and this could be a situation where it's new for investors in terms of getting to know
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot